alx-0600 and Cardiovascular-Diseases

alx-0600 has been researched along with Cardiovascular-Diseases* in 1 studies

Other Studies

1 other study(ies) available for alx-0600 and Cardiovascular-Diseases

Article	Year
A Patient With Parenteral Nutrition-Dependent Short Bowel Syndrome and Cardiovascular Disease With 4-Year Exposure to Teduglutide. JPEN. Journal of parenteral and enteral nutrition, 2016, Volume: 40, Issue:5 Clinical trials of the glucagon-like peptide 2 analogue teduglutide resulted in approval of the drug by the Food and Drug Administration in 2012 as a treatment for parenteral nutrition-dependent short bowel syndrome in adults. This report presents the case study of a man with short bowel syndrome caused by portal vein thrombosis who had 4 years exposure to the drug at the time of his death due to cardiovascular disease. Topics: Cardiovascular Diseases; Fatal Outcome; Gastrointestinal Agents; Heart Failure; Humans; Male; Middle Aged; Parenteral Nutrition; Peptides; Portal Vein; Randomized Controlled Trials as Topic; Short Bowel Syndrome; Thrombosis	2016

Article

Year

A Patient With Parenteral Nutrition-Dependent Short Bowel Syndrome and Cardiovascular Disease With 4-Year Exposure to Teduglutide.

JPEN. Journal of parenteral and enteral nutrition, 2016, Volume: 40, Issue:5

Clinical trials of the glucagon-like peptide 2 analogue teduglutide resulted in approval of the drug by the Food and Drug Administration in 2012 as a treatment for parenteral nutrition-dependent short bowel syndrome in adults. This report presents the case study of a man with short bowel syndrome caused by portal vein thrombosis who had 4 years exposure to the drug at the time of his death due to cardiovascular disease.

Topics: Cardiovascular Diseases; Fatal Outcome; Gastrointestinal Agents; Heart Failure; Humans; Male; Middle Aged; Parenteral Nutrition; Peptides; Portal Vein; Randomized Controlled Trials as Topic; Short Bowel Syndrome; Thrombosis

2016